Cite
Design, synthesis and biological evaluation of (R)-5-methylpyrrolidin-2-ones as p300 bromodomain inhibitors with Anti-Tumor activities in multiple tumor lines.
MLA
Liu, Ruiqi, et al. “Design, Synthesis and Biological Evaluation of (R)-5-Methylpyrrolidin-2-Ones as P300 Bromodomain Inhibitors with Anti-Tumor Activities in Multiple Tumor Lines.” Bioorganic Chemistry, vol. 124, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bioorg.2022.105803.
APA
Liu, R., Yang, H., Chen, Z., Zhou, K., Shi, Q., Li, J., Huang, Y., Huang, X., & Li, Y. (2022). Design, synthesis and biological evaluation of (R)-5-methylpyrrolidin-2-ones as p300 bromodomain inhibitors with Anti-Tumor activities in multiple tumor lines. Bioorganic Chemistry, 124, N.PAG. https://doi.org/10.1016/j.bioorg.2022.105803
Chicago
Liu, Ruiqi, Hong Yang, Zonglong Chen, Kaixin Zhou, Qiongyu Shi, Jiayi Li, Yuting Huang, Xun Huang, and Yingxia Li. 2022. “Design, Synthesis and Biological Evaluation of (R)-5-Methylpyrrolidin-2-Ones as P300 Bromodomain Inhibitors with Anti-Tumor Activities in Multiple Tumor Lines.” Bioorganic Chemistry 124 (July): N.PAG. doi:10.1016/j.bioorg.2022.105803.